Drug interactions: Volatile anesthetics and opioids

Journal of Clinical Anesthesia

Volumn 9, Issue 6 SUPPL., 1997, Pages 18S-22S

  Glass, Peter S A ^a   Gan, Tong J ^a   Howell, Scott ^a   Ginsberg, Brian ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amnesia; Analgesia; Anesthesia, intravenous; Anesthetics, volatile: pharmacodynamic, pharmacokinetic interactions; Drug interactions; Fentanyl; Hypnosis; Isoflurane; Opioids; Propofol; Remifentanil

Indexed keywords

ALFENTANIL; FENTANYL; FENTANYL DERIVATIVE; INHALATION ANESTHETIC AGENT; ISOFLURANE; OPIATE AGONIST; PROPOFOL; REMIFENTANIL; SUFENTANIL;

AMNESIA; ANALGESIA; ANESTHETIC RECOVERY; CONFERENCE PAPER; DRUG ELIMINATION; DRUG POTENCY; HUMAN; HYPNOSIS; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM LUNG ALVEOLUS CONCENTRATION; PRIORITY JOURNAL;

EID: 0030740451     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(97)00122-0     Document Type: Conference Paper

References (18)

1. Eger EI 2d, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration a standard of anesthetic potency . Anesthesiology. 26:1965;756-763.
2. Sear JW. Drug interactions and adverse reactions. Bailliere's Clinical Anaesthesiol (Bailliere Tindall). 5:1991;703-733.
3. Mueller RA, Lundberg DB. Philosophy and theory. Mueller RA, Lundberg DBA. Drug Interactions for Anesthesiology. 2d ed :1992;3-19 Churchill Livingstone, New York.
4. Glass PS, Shafer SL, Jacobs JR, Reves JG. Intravenous drug delivery systems. Miller RD. Anesthesia 4th ed. 1994;389-416 Churchill Livingstone, New York.
5. McEwan AI, Smith C, Dyar O, Goodman D, Smith LR, Glass PS. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology. 78:1993;864-869.
6. Lehmann KA, Heinrich C, van Heiss R. Balanced anesthesia and patient-controlled postoperative analgesia with fentanyl minimum effective concentrations, accumulation and acute tolerance . Acta Anaesthesiol Belg. 39:1988;11-23.
7. Dwyer R, Bennett HL, Eger EI 2d, Peterson N. Isoflurane anesthesia prevents unconscious learning. Anesth Analg. 75:1992;107-112.
8. Westmoreland CL, Sebel PS, Gropper A. Fentanyl or alfentanil decreases the minimal alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg. 78:1994;23-28.
9. Brunner MD, Braithwaite P, Jhaveri R, et al. MAC reduction of isoflurane by sufentanil. Br J Anaesth. 72:1994;42-46.
10. Lang E, Kapila A, Shlugman D, Hoke JF, Sebel PS, Glass PS. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology. 85:1996;721-728.
11. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid remifentanil (GI87084B) . Anesth Analg. 77:1993;1031-1040.
12. Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology. 79:1993;893-903.
13. Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 80:1993;881-892.
14. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P: Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane and alfentanil in normal volunteers. Anesthesiology, (in press).
15. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 76:1992;334-341.
16. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 74:1991;53-63.
17. Vuyk J, Lim T, Engbers FH, Burm AG, Vletter AA, Bovill JG. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in female patients. Anesthesiology. 83:1995;8-22.
18. 50 of propofol for loss of consciousness and skin incision. Anesthesiology. 81:1994;820-828.